Atommap Corp
Last verified 2026-06-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $59.6Mattributed |
|---|---|
| Latest round | Funding round, $59.6M, 2026-03-20attributed |
| Founded | unknown |
| Headquarters | New York, New York |
| Industry | biotechnology |
| Stage | unknown |
| Website | atommapper.com |
Fathom Therapeutics, formerly Atommap, uses quantum chemistry and AI to design small-molecule drugs by simulating protein motion at atomic resolution. It serves drug discovery through an internal pipeline and partnerships.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-20 | Funding round | $59.6M | undisclosed |
Detected tech stack
astro 6.1.7, hsts, vercel
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $59.6M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $59.6M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | atommapper.com, read 2026-06-05 |
| Description | self-reported | atommapper.com, read 2026-06-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $59.6M, 2026-03-20 → Funding round, $59.6M, 2026-03-20, sec-edgar, No document URL on file | Latest round | seed, $59.6M, 2026-03-20 → Funding round, $59.6M, 2026-03-20 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes